ArticleInternational journal of general medicine2023

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis.

Wen-Zhao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.